Recent Updates
Recently added Catalysts
VNDA Neutral Sentiment

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025

Key Takeaway: Vanda Pharmaceuticals Inc. will announce its fourth quarter and full year 2024 financial results on February 13, 2025, after market close. A conference call is scheduled for the same day at 4:30 PM ET, where management will discuss the results and other corporate activities. Investors can participate in the call and will have access to a replay afterward. This announcement indicates Vanda's ongoing communication with shareholders regarding its financial performance.
Price reaction · baseline $4.48 (2025-02-04 close) · hit after-hours · clean, no other VNDA news in the window
day 0 close · peak
+1.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcement of upcoming financial results may signal strong performance.
  • Engagement with investors through a conference call enhances transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis

Full Press Release Details

Conference Call and Webcast to Follow
WASHINGTON, Feb. 5, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the fourth quarter and full year 2024 on Thursday, February 13, 2025, after the market closes.
Vanda will host a conference call at 4:30 PM ET on Thursday, February 13, 2025, during which management will discuss the fourth quarter and full year 2024 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 2881765.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Thursday, February 13, 2025, beginning at 8:30 PM ET and will be accessible until Thursday, February 20, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 2881765.
About Vanda Pharmaceuticals Inc.
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies

Frequently Asked Questions

When will Vanda Pharmaceuticals release its Q4 2024 results?

Vanda Pharmaceuticals will release its Q4 2024 results on February 13, 2025.

What time is the Vanda conference call scheduled?

The conference call is set for 4:30 PM ET on February 13, 2025.

How can I access the conference call?

Dial 1-800-715-9871 for domestic or 1-646-307-1963 for international access.

Will there be a replay of the conference call?

Yes, a replay will be available starting at 8:30 PM ET on February 13, 2025.

Where can I find more information about Vanda?

More information is available on Vanda's website at www.vandapharma.com.

Last updated: Feb 5, 2025